ID   DYRK2_HUMAN             Reviewed;         528 AA.
AC   Q92630-2;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   12-JUN-2007, sequence version 3.
DT   12-OCT-2022, entry version 213.
DE   RecName: Full=Isoform 2 of Dual specificity tyrosine-phosphorylation-regulated kinase 2;
DE            EC=2.7.12.1 {ECO:0000269|PubMed:22998443};
GN   Name=DYRK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, COFACTOR,
RP   PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9748265; DOI=10.1074/jbc.273.40.25893;
RA   Becker W., Weber Y., Wetzel K., Eirmbter K., Tejedor F.J., Joost H.-G.;
RT   "Sequence characteristics, subcellular localization, and substrate
RT   specificity of DYRK-related kinases, a novel family of dual specificity
RT   protein kinases.";
RL   J. Biol. Chem. 273:25893-25902(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 320-528 (ISOFORMS 1/2).
RC   TISSUE=Placenta;
RA   Becker W., Joost H.-G.;
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION.
RX   PubMed=11311121; DOI=10.1042/bj3550609;
RA   Woods Y.L., Cohen P., Becker W., Jakes R., Goedert M., Wang X., Proud C.G.;
RT   "The kinase DYRK phosphorylates protein-synthesis initiation factor
RT   eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at
RT   Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming
RT   kinase.";
RL   Biochem. J. 355:609-615(2001).
RN   [7]
RP   INDUCTION IN CANCER.
RX   PubMed=12874018;
RA   Miller C.T., Aggarwal S., Lin T.K., Dagenais S.L., Contreras J.I.,
RA   Orringer M.B., Glover T.W., Beer D.G., Lin L.;
RT   "Amplification and overexpression of the dual-specificity tyrosine-(Y)-
RT   phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung
RT   adenocarcinomas.";
RL   Cancer Res. 63:4136-4143(2003).
RN   [8]
RP   FUNCTION.
RX   PubMed=12588975; DOI=10.1128/mcb.23.5.1546-1557.2003;
RA   Wang X., Li W., Parra J.L., Beugnet A., Proud C.G.;
RT   "The C terminus of initiation factor 4E-binding protein 1 contains multiple
RT   regulatory features that influence its function and phosphorylation.";
RL   Mol. Cell. Biol. 23:1546-1557(2003).
RN   [9]
RP   FUNCTION.
RX   PubMed=14593110; DOI=10.1074/jbc.m301769200;
RA   Skurat A.V., Dietrich A.D.;
RT   "Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family
RT   protein kinases.";
RL   J. Biol. Chem. 279:2490-2498(2004).
RN   [10]
RP   INTERACTION WITH CCNL2.
RX   PubMed=14623875; DOI=10.1074/jbc.m310794200;
RA   de Graaf K., Hekerman P., Spelten O., Herrmann A., Packman L.C., Bussow K.,
RA   Muller-Newen G., Becker W.;
RT   "Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich
RT   domain: phosphorylation by DYRK1A and colocalization with splicing
RT   factors.";
RL   J. Biol. Chem. 279:4612-4624(2004).
RN   [11]
RP   FUNCTION.
RX   PubMed=15910284; DOI=10.1042/bj20050733;
RA   Auld G.C., Campbell D.G., Morrice N., Cohen P.;
RT   "Identification of calcium-regulated heat-stable protein of 24 kDa
RT   (CRHSP24) as a physiological substrate for PKB and RSK using KESTREL.";
RL   Biochem. J. 389:775-783(2005).
RN   [12]
RP   FUNCTION AS CRMP4/DPYSL3 KINASE, AND ACTIVITY REGULATION BY PURVALANOL.
RX   PubMed=16611631; DOI=10.1074/jbc.m513344200;
RA   Cole A.R., Causeret F., Yadirgi G., Hastie C.J., McLauchlan H.,
RA   McManus E.J., Hernandez F., Eickholt B.J., Nikolic M., Sutherland C.;
RT   "Distinct priming kinases contribute to differential regulation of
RT   collapsin response mediator proteins by glycogen synthase kinase-3 in
RT   vivo.";
RL   J. Biol. Chem. 281:16591-16598(2006).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH NFATC1.
RX   PubMed=16511445; DOI=10.1038/nature04631;
RA   Gwack Y., Sharma S., Nardone J., Tanasa B., Iuga A., Srikanth S.,
RA   Okamura H., Bolton D., Feske S., Hogan P.G., Rao A.;
RT   "A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as
RT   regulators of NFAT.";
RL   Nature 441:646-650(2006).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17349958; DOI=10.1016/j.molcel.2007.02.007;
RA   Taira N., Nihira K., Yamaguchi T., Miki Y., Yoshida K.;
RT   "DYRK2 is targeted to the nucleus and controls p53 via Ser46
RT   phosphorylation in the apoptotic response to DNA damage.";
RL   Mol. Cell 25:725-738(2007).
RN   [15]
RP   FUNCTION IN APOPTOSIS AS P53/TP53 KINASE, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION BY ATM, AND GENE FAMILY.
RX   PubMed=18599021; DOI=10.1016/j.bcp.2008.05.021;
RA   Yoshida K.;
RT   "Role for DYRK family kinases on regulation of apoptosis.";
RL   Biochem. Pharmacol. 76:1389-1394(2008).
RN   [16]
RP   FUNCTION, AND PHOSPHORYLATION AT THR-381 AND SER-449.
RX   PubMed=18455992; DOI=10.1016/j.cell.2008.02.047;
RA   Varjosalo M., Bjorklund M., Cheng F., Syvanen H., Kivioja T., Kilpinen S.,
RA   Sun Z., Kallioniemi O., Stunnenberg H.G., He W.W., Ojala P., Taipale J.;
RT   "Application of active and kinase-deficient kinome collection for
RT   identification of kinases regulating hedgehog signaling.";
RL   Cell 133:537-548(2008).
RN   [17]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18539531; DOI=10.1016/j.molmed.2008.05.003;
RA   Yoshida K.;
RT   "Nuclear trafficking of pro-apoptotic kinases in response to DNA damage.";
RL   Trends Mol. Med. 14:305-313(2008).
RN   [18]
RP   ACTIVITY REGULATION BY HARMINE.
RX   PubMed=19796173; DOI=10.1111/j.1742-4658.2009.07346.x;
RA   Goeckler N., Jofre G., Papadopoulos C., Soppa U., Tejedor F.J., Becker W.;
RT   "Harmine specifically inhibits protein kinase DYRK1A and interferes with
RT   neurite formation.";
RL   FEBS J. 276:6324-6337(2009).
RN   [19]
RP   FUNCTION IN E3 LIGASE REGULATION, FUNCTION AS KATNA1 KINASE, AND
RP   INTERACTION WITH EDVP COMPLEX.
RX   PubMed=19287380; DOI=10.1038/ncb1848;
RA   Maddika S., Chen J.;
RT   "Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3
RT   ligase.";
RL   Nat. Cell Biol. 11:409-419(2009).
RN   [20]
RP   ACTIVITY REGULATION BY ACRIDINE ANALOGS.
RX   PubMed=20836251; DOI=10.1016/j.bmcl.2010.04.150;
RA   Cuny G.D., Robin M., Ulyanova N.P., Patnaik D., Pique V., Casano G.,
RA   Liu J.-F., Lin X., Xian J., Glicksman M.A., Stein R.L., Higgins J.M.G.;
RT   "Structure-activity relationship study of acridine analogs as haspin and
RT   DYRK2 kinase inhibitors.";
RL   Bioorg. Med. Chem. Lett. 20:3491-3494(2010).
RN   [21]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-106 AND SER-442 BY ATM,
RP   UBIQUITINATION BY MDM2, INTERACTION WITH MDM2, MUTAGENESIS OF THR-106;
RP   SER-442 AND 189-LYS--ARG-191, NUCLEAR LOCALIZATION SIGNAL, AND INDUCTION BY
RP   DNA DAMAGE.
RX   PubMed=19965871; DOI=10.1074/jbc.m109.042341;
RA   Taira N., Yamamoto H., Yamaguchi T., Miki Y., Yoshida K.;
RT   "ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the
RT   apoptotic response to DNA damage.";
RL   J. Biol. Chem. 285:4909-4919(2010).
RN   [22]
RP   FUNCTION.
RX   PubMed=22307329; DOI=10.1172/jci60818;
RA   Taira N., Mimoto R., Kurata M., Yamaguchi T., Kitagawa M., Miki Y.,
RA   Yoshida K.;
RT   "DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle
RT   progression in human cancer cells.";
RL   J. Clin. Invest. 122:859-872(2012).
RN   [23]
RP   FUNCTION, AND UBIQUITINATION BY SIAH2.
RX   PubMed=22878263; DOI=10.1093/jmcb/mjs047;
RA   Perez M., Garcia-Limones C., Zapico I., Marina A., Schmitz M.L., Munoz E.,
RA   Calzado M.A.;
RT   "Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic
RT   signaling pathways.";
RL   J. Mol. Cell Biol. 4:316-330(2012).
RN   [24]
RP   FUNCTION, AND MUTAGENESIS OF LYS-251.
RX   PubMed=23362280; DOI=10.1074/jbc.m112.416792;
RA   Jung H.Y., Wang X., Jun S., Park J.I.;
RT   "Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT
RT   degradation.";
RL   J. Biol. Chem. 288:7252-7262(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 146-552 IN COMPLEX WITH
RP   INDIRUBIN.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of dual-specificity tyrosine phosphorylation regulated
RT   kinase 2 (DYRK2) in complex with an indirubin ligand.";
RL   Submitted (JAN-2010) to the PDB data bank.
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 146-540 IN COMPLEX WITH
RP   LEUCETTAMINE DERIVATIVE, PHOSPHORYLATION AT TYR-382, AUTOPHOSPHORYLATION,
RP   ACTIVITY REGULATION, AND CATALYTIC ACTIVITY.
RX   PubMed=22998443; DOI=10.1021/jm301034u;
RA   Tahtouh T., Elkins J.M., Filippakopoulos P., Soundararajan M., Burgy G.,
RA   Durieu E., Cochet C., Schmid R.S., Lo D.C., Delhommel F., Oberholzer A.E.,
RA   Pearl L.H., Carreaux F., Bazureau J.P., Knapp S., Meijer L.;
RT   "Selectivity, cocrystal structures, and neuroprotective properties of
RT   leucettines, a family of protein kinase inhibitors derived from the marine
RT   sponge alkaloid leucettamine B.";
RL   J. Med. Chem. 55:9312-9330(2012).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.36 ANGSTROMS) OF 146-552.
RX   PubMed=23665168; DOI=10.1016/j.str.2013.03.012;
RA   Soundararajan M., Roos A.K., Savitsky P., Filippakopoulos P.,
RA   Kettenbach A.N., Olsen J.V., Gerber S.A., Eswaran J., Knapp S.,
RA   Elkins J.M.;
RT   "Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase
RT   activation and substrate recognition.";
RL   Structure 21:986-996(2013).
RN   [29]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-98; LEU-198; ASN-245; SER-295; GLN-451
RP   AND TYR-455.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92630-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92630-2; Sequence=VSP_026115;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS8979.1; -.
DR   RefSeq; NP_003574.1; NM_003583.3.
DR   RefSeq; XP_016875521.1; XM_017020032.1.
DR   ProteomicsDB; 75388; -.
DR   Ensembl; ENST00000393555.3; ENSP00000377186.3; ENSG00000127334.11.
DR   Proteomes; UP000005640; Chromosome 12.
PE   1: Evidence at protein level;
SQ   SEQUENCE   528 AA;  59715 MW;  AF2C6822ED9522D7 CRC64;
     MNDHLHVGSH AHGQIQVQQL FEDNSNKRTV LTTQPNGLTT VGKTGLPVVP ERQLDSIHRR
     QGSSTSLKSM EGMGKVKATP MTPEQAMKQY MQKLTAFEHH EIFSYPEIYF LGLNAKKRQG
     MTGGPNNGGY DDDQGSYVQV PHDHVAYRYE VLKVIGKGSF GQVVKAYDHK VHQHVALKMV
     RNEKRFHRQA AEEIRILEHL RKQDKDNTMN VIHMLENFTF RNHICMTFEL LSMNLYELIK
     KNKFQGFSLP LVRKFAHSIL QCLDALHKNR IIHCDLKPEN ILLKQQGRSG IKVIDFGSSC
     YEHQRVYTYI QSRFYRAPEV ILGARYGMPI DMWSLGCILA ELLTGYPLLP GEDEGDQLAC
     MIELLGMPSQ KLLDASKRAK NFVSSKGYPR YCTVTTLSDG SVVLNGGRSR RGKLRGPPES
     REWGNALKGC DDPLFLDFLK QCLEWDPAVR MTPGQALRHP WLRRRLPKPP TGEKTSVKRI
     TESTGAITSI SKLPPPSSSA SKLRTNLAQM TDANGNIQQR TVLPKLVS
//
